DOLUTEGRAVIR USE IS ASSOCIATED WITH HIGHER POSTPARTUM WEIGHT COMPARED TO EFAVIRENZ
Postpartum weight retention impacts cardiometabolic risk. Recent studies show higher weight gain with dolutegravir (DTG)-based antiretroviral therapy (ART) compared to other ART. We assessed the association of DTG with postpartum weight over time in women with HIV (WHIV) in Botswana using comparator groups of women on efavirenz (EFV) and HIV-negative (HIV-) women. The Tshilo Dikotla…